MarkNtel Advisors recently published a detailed industry analysis of the Global Radiopharmaceuticals Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
Global Radiopharmaceuticals Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030
The Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2024 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30.
What are the major Driver the Global Radiopharmaceuticals Market?
Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.
With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals.
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html
What segments define the Global Radiopharmaceuticals Market from 2025 to 2030? How do these segments contribute to market dynamics and growth?
By Radioisotope
- Technetium 99- Market Size & Forecast 2020-2030, USD Million
- Fluorine 18- Market Size & Forecast 2020-2030, USD Million
- Iodine 131- Market Size & Forecast 2020-2030, USD Million
- Gallium 68- Market Size & Forecast 2020-2030, USD Million
- Iodine 123- Market Size & Forecast 2020-2030, USD Million
- Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2020-2030, USD Million
By Indication
- Oncology- Market Size & Forecast 2020-2030, USD Million
- Cardiology- Market Size & Forecast 2020-2030, USD Million
- Gastroenterology- Market Size & Forecast 2020-2030, USD Million
- Nephrology- Market Size & Forecast 2020-2030, USD Million
- Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2020-2030, USD Million
According to report, The Oncology segment held a major share of the Global Radiopharmaceuticals Market.
By Type
- Diagnostic- Market Size & Forecast 2020-2030, USD Million
- Therapeutic- Market Size & Forecast 2020-2030, USD Million
By End User
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Medical Imaging Centers- Market Size & Forecast 2020-2030, USD Million
- Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2020-2030, USD Million
According to report, Hospitals account for the largest share in the Global Radiopharmaceuticals Market.
Explore the Complete Global Radiopharmaceuticals Market Analysis Report – https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html
Geographical Analysis: Global Radiopharmaceuticals Market
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Global Radiopharmaceuticals Market Share & Competitive Landscape:
The Radiopharmaceuticals Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry’s leading companies, highlighting their strengths, financial performance, and market influence.
Leading Companies in the Global Radiopharmaceuticals Market are:
- Bayer AG
- Iso-Tex Diagnostics, Inc.
- Jubilant Pharmova Limited
- Novartis AG
- General Electric Company
- Lantheus Holdings, Inc.
- Eli Lilly and Company
- Siemens Healthineers AG
- Curium Pharma
- Cardinal Health
- Blue Earth Diagnostics, Inc. (Bracco Group)
- Acrotech Biopharm
- Northstar Medical Technologies LLC
- IBA Radiopharma Solutions
- Sun Pharmaceutical Industries, Inc.
Global Radiopharmaceuticals Market Recent Development:
- 2023: Curium Pharma announced that the European Commission has granted marketing authorization for PYLCLARI™, a radiopharmaceutical indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in adults with prostate cancer.
- 2023: Eli Lilly and Company agreed to acquire the radiopharmaceutical firm POINT Biopharma Global for USD 1.4 billion.
Questions Addressed in this Study
1.What factors are driving the Global Radiopharmaceuticals Market growth?
2.How is the Global Radiopharmaceuticals Market expected to grow over the next five years?
3.What are the key insights into the current trends in the Global Radiopharmaceuticals Market?
4.What is the current size of the Global Radiopharmaceuticals Market, and how is it projected to change in the future?
6.What is the future outlook for the Global Radiopharmaceuticals Market in terms of technological advancements and market expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/radiopharmaceuticals-market.html
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
More Research Studies Report:
–Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.
–Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.
For Media Inquiries, Please Contact:
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
